GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » Piotroski F-Score

Formycon AG (XTER:FYB) Piotroski F-Score : 4 (As of May. 27, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Formycon AG Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Formycon AG has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Formycon AG's Piotroski F-Score or its related term are showing as below:

XTER:FYB' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 7
Current: 4

During the past 13 years, the highest Piotroski F-Score of Formycon AG was 7. The lowest was 1. And the median was 4.


Formycon AG Piotroski F-Score Historical Data

The historical data trend for Formycon AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formycon AG Piotroski F-Score Chart

Formycon AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 3.00 2.00 4.00 4.00

Formycon AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 - 4.00 - 4.00

Competitive Comparison of Formycon AG's Piotroski F-Score

For the Biotechnology subindustry, Formycon AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formycon AG's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formycon AG's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Formycon AG's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was €75.80 Mil.
Cash Flow from Operations was €-9.85 Mil.
Revenue was €77.70 Mil.
Gross Profit was €23.31 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (853.697 + 890.362) / 2 = €872.0295 Mil.
Total Assets at the begining of this year (Dec22) was €853.70 Mil.
Long-Term Debt & Capital Lease Obligation was €7.82 Mil.
Total Current Assets was €67.15 Mil.
Total Current Liabilities was €69.31 Mil.
Net Income was €35.99 Mil.

Revenue was €42.50 Mil.
Gross Profit was €12.07 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (67.342 + 853.697) / 2 = €460.5195 Mil.
Total Assets at the begining of last year (Dec21) was €67.34 Mil.
Long-Term Debt & Capital Lease Obligation was €7.59 Mil.
Total Current Assets was €30.50 Mil.
Total Current Liabilities was €50.67 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Formycon AG's current Net Income (TTM) was 75.80. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Formycon AG's current Cash Flow from Operations (TTM) was -9.85. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=75.795/853.697
=0.08878443

ROA (Last Year)=Net Income/Total Assets (Dec21)
=35.992/67.342
=0.53446586

Formycon AG's return on assets of this year was 0.08878443. Formycon AG's return on assets of last year was 0.53446586. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Formycon AG's current Net Income (TTM) was 75.80. Formycon AG's current Cash Flow from Operations (TTM) was -9.85. ==> -9.85 <= 75.80 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=7.815/872.0295
=0.00896185

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=7.594/460.5195
=0.01649007

Formycon AG's gearing of this year was 0.00896185. Formycon AG's gearing of last year was 0.01649007. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=67.147/69.305
=0.96886228

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=30.502/50.667
=0.6020092

Formycon AG's current ratio of this year was 0.96886228. Formycon AG's current ratio of last year was 0.6020092. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Formycon AG's number of shares in issue this year was 16.049. Formycon AG's number of shares in issue last year was 13.884. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=23.305/77.696
=0.29995109

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=12.071/42.497
=0.28404358

Formycon AG's gross margin of this year was 0.29995109. Formycon AG's gross margin of last year was 0.28404358. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=77.696/853.697
=0.09101121

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=42.497/67.342
=0.63106234

Formycon AG's asset turnover of this year was 0.09101121. Formycon AG's asset turnover of last year was 0.63106234. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+0+0+1+1+0+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Formycon AG has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Formycon AG  (XTER:FYB) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Formycon AG Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Formycon AG's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Formycon AG (XTER:FYB) Business Description

Traded in Other Exchanges
Address
Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID 19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.
Executives
Dr. Stefan Glombitza Board of Directors
Dr. Carsten Brockmeyer Board of Directors
Dr. Nicolas Combé Board of Directors

Formycon AG (XTER:FYB) Headlines

No Headlines